Clinical Trial Update: Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp® [NA]

View source ↗

Summary

A clinical trial update reporting results from evaluating the MiniMed 780G automated insulin delivery system in adults and pediatric subjects with Type 1 diabet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• MiniMed 780G System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Type 1 Diabetes | NA | Status: COMPLETED | Results posted: 2025-06-22